Knocking out drug-resistant TB with a one-two punch

Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that blocks bacterial transcription and forms the cornerstone of a multidrug regimen—and rising drug resistance has revealed the limits of leaning so heavily on a single point of attack.